FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387518410> ?p ?o ?g. }

• W4387518410 abstract "Introduction Prostate cancer (PCa) presents a significant health challenge in men, with a substantial number of deaths attributed to metastatic castration resistant PCa (mCRPC). Moreover, African American men experience disproportionately high mortality rates due to PCa. This study delves into the pivotal role of SPDEF, a prostate specific Ets transcription factor, and its regulation by DNA methylation in the context of PCa progression. Methods We performed Epigenetic reprogramming using daily treatment with non-toxic dose of 5Aza-2-deoxycytidine (5Aza-dC) for two weeks to assess its impact on PDEF expression in prostate cancer cells. Next, we conducted functional studies on reprogrammed cells, including cell migration (wound-healing assay), invasion (Boyden-Chamber test), and proliferation (MTT assay) to comprehensively evaluate the consequences of altered PDEF expression. We used bisulfite sequencing (BSP) to examine DNA methylation at SPDEF promoter. Simultaneously, we utilized siRNA-mediated targeting of key DNMTs (DNMT1, DNMT3A, and DNMT3B) to elucidate their specific role in regulating PDEF. We measured mRNA and protein expressions using qRT-PCR and immune-blotting techniques, respectively. Results In this report, we observed that: a) there is a gradual decrease in SPDEF expression with a concomitant increase in methylated CpG sites within the SPDEF gene during prostate cancer progression from lower to higher Gleason grade; b) Expression of DNMT’s (DNMT1, 3a and 3b) is increased during prostate cancer progression, and there is an inverse correlation between SPDEF and DNMT expression; c) SPDEF levels are decreased in RC77/T, a line of PCa cells from African American origin similar to PC3 and DU145 cells (CRPC cells), as compared to LNCaP cells , a line of androgen dependent cells,; d) the 5′ CpG island of SPDEF gene are hypermethylated in SPDEF-negative CRPC ( PC3, DU145 and RC77/T) cell lines but the same regions are hypomethylated in SPDEF-positive castrate sensitive (LNCaP) cell line ; (e) expression of SPDEF in PCa cells lacking SPDEF decreases cell migration and invasion, but has no significant effect on cell proliferation, and; (f) treatment with the demethylating agent, 5-aza-2′-deoxycytidine, or silencing of the DNMT’s by siRNA, partially restores SPDEF expression in SPDEF-negative PCa cell lines, and decreases cell migration and invasion. Discussion These results indicate hypermethylation is a prevalent mechanism for decreasing SPDEF expression during prostate cancer progression. The data demonstrate that loss of SPDEF expression in prostate cancer cells, a critical step in cellular plasticity, results from a potentially reversible process of aberrant DNA methylation. These studies suggest DMNT activity as a potential therapeutic vulnerability that can be exploited for limiting cellular plasticity, tumor progression, and therapy resistance in prostate cancer." @default.
• W4387518410 created "2023-10-12" @default.
• W4387518410 creator A5004037751 @default.
• W4387518410 creator A5011661577 @default.
• W4387518410 creator A5037312238 @default.
• W4387518410 creator A5053019599 @default.
• W4387518410 creator A5067910048 @default.
• W4387518410 creator A5074581672 @default.
• W4387518410 date "2023-10-11" @default.
• W4387518410 modified "2023-10-18" @default.
• W4387518410 title "Regulation of SPDEF expression by DNA methylation in advanced prostate cancer" @default.
• W4387518410 cites W1486257535 @default.
• W4387518410 cites W1528741560 @default.
• W4387518410 cites W1699926620 @default.
• W4387518410 cites W1784857457 @default.
• W4387518410 cites W1899099918 @default.
• W4387518410 cites W1972444582 @default.
• W4387518410 cites W1997350485 @default.
• W4387518410 cites W1997602974 @default.
• W4387518410 cites W1997614722 @default.
• W4387518410 cites W2001526794 @default.
• W4387518410 cites W2003955264 @default.
• W4387518410 cites W2004966039 @default.
• W4387518410 cites W2027519787 @default.
• W4387518410 cites W2030148608 @default.
• W4387518410 cites W2051025382 @default.
• W4387518410 cites W2062365665 @default.
• W4387518410 cites W2062721883 @default.
• W4387518410 cites W2064363002 @default.
• W4387518410 cites W2080120292 @default.
• W4387518410 cites W2084203180 @default.
• W4387518410 cites W2089287002 @default.
• W4387518410 cites W2099962549 @default.
• W4387518410 cites W2106364888 @default.
• W4387518410 cites W2110534364 @default.
• W4387518410 cites W2119959279 @default.
• W4387518410 cites W2127851117 @default.
• W4387518410 cites W2132270233 @default.
• W4387518410 cites W2133918562 @default.
• W4387518410 cites W2136566036 @default.
• W4387518410 cites W2141476381 @default.
• W4387518410 cites W2145750252 @default.
• W4387518410 cites W2146883005 @default.
• W4387518410 cites W2148643283 @default.
• W4387518410 cites W2153828766 @default.
• W4387518410 cites W2155961243 @default.
• W4387518410 cites W2158900087 @default.
• W4387518410 cites W2161881624 @default.
• W4387518410 cites W2262087934 @default.
• W4387518410 cites W2515193564 @default.
• W4387518410 cites W2572742978 @default.
• W4387518410 cites W2608458533 @default.
• W4387518410 cites W2766704091 @default.
• W4387518410 cites W2801540524 @default.
• W4387518410 cites W2806657853 @default.
• W4387518410 cites W2904355372 @default.
• W4387518410 cites W2912991678 @default.
• W4387518410 cites W2943005115 @default.
• W4387518410 cites W2947014957 @default.
• W4387518410 cites W2964673115 @default.
• W4387518410 cites W2974355375 @default.
• W4387518410 cites W2980852974 @default.
• W4387518410 cites W2994848839 @default.
• W4387518410 cites W3084238852 @default.
• W4387518410 cites W3147142721 @default.
• W4387518410 cites W3167169834 @default.
• W4387518410 cites W3176749558 @default.
• W4387518410 cites W4206841660 @default.
• W4387518410 cites W4233256296 @default.
• W4387518410 cites W4312140970 @default.
• W4387518410 cites W4313816344 @default.
• W4387518410 cites W58950010 @default.
• W4387518410 doi "https://doi.org/10.3389/fendo.2023.1156120" @default.
• W4387518410 hasPublicationYear "2023" @default.
• W4387518410 type Work @default.
• W4387518410 citedByCount "0" @default.
• W4387518410 crossrefType "journal-article" @default.
• W4387518410 hasAuthorship W4387518410A5004037751 @default.
• W4387518410 hasAuthorship W4387518410A5011661577 @default.
• W4387518410 hasAuthorship W4387518410A5037312238 @default.
• W4387518410 hasAuthorship W4387518410A5053019599 @default.
• W4387518410 hasAuthorship W4387518410A5067910048 @default.
• W4387518410 hasAuthorship W4387518410A5074581672 @default.
• W4387518410 hasBestOaLocation W43875184101 @default.
• W4387518410 hasConcept C104317684 @default.
• W4387518410 hasConcept C121608353 @default.
• W4387518410 hasConcept C140173407 @default.
• W4387518410 hasConcept C150194340 @default.
• W4387518410 hasConcept C175211621 @default.
• W4387518410 hasConcept C189235521 @default.
• W4387518410 hasConcept C190727270 @default.
• W4387518410 hasConcept C2777142704 @default.
• W4387518410 hasConcept C2779979206 @default.
• W4387518410 hasConcept C2780192828 @default.
• W4387518410 hasConcept C33288867 @default.
• W4387518410 hasConcept C41091548 @default.
• W4387518410 hasConcept C50171091 @default.
• W4387518410 hasConcept C502942594 @default.
• W4387518410 hasConcept C54355233 @default.
• W4387518410 hasConcept C86803240 @default.

• next